title: Physical Activity Participation and Preferences: Developmental and Oncology-Related Transitions in Adolescents Treated for Cancer.
abstract: OBJECTIVE
  To describe motor function and participation in, barriers to, and preferences for physical activity (PA) in adolescents during and after treatment of cancer and to discuss PA promotion in the context of developmental and cancer transitions.
  
  
  METHODS
  A cross-sectional survey study used the Transfer and Basic Mobility and Sports/Physical Functioning self-report and parent-report scales of the Pediatric Outcomes Data Collection Instrument (PODCI) and questions about PA participation and preferences to collect information from 80 adolescents and 63 parents.
  
  
  RESULTS
  PODCI scores for adolescents receiving treatment were more variable and significantly lower than those of adolescents who had been off treatment for more than 2 years. Fatigue, pain, general health, and doctor's orders were frequently identified as barriers to PA for adolescents receiving treatment. Many did not achieve recommended levels of PA. The adolescents expressed preferences for being active with friends and family, at home or in school, in the afternoon or evening, and through daily recreational and sports activities typical of teenagers.
  
  
  CONCLUSIONS
  Physical abilities and participation in and barriers to PA vary across the cancer journey. Interventions should be sensitive to variability and acknowledge individual preferences and environments throughout the trajectories and transitions of cancer treatment and youth development to achieve lifelong healthy lifestyles.
authors.affiliation: McMaster Children's Hospital; School of Rehabilitation Sciences and Department of Pediatrics, McMaster University, Hamilton, Ont.
authors.forename: Marilyn
authors.initials: M
authors.lastname: Wright
keywords: adolescent; cancer; physical activity
references.citation: Appl Physiol Nutr Metab. 2011 Feb;36(1):36-46; 47-58
references.pmid: 21326376
references.citation: J Clin Oncol. 2009 May 10;27(14):2363-73
references.pmid: 19255308
references.citation: Eur J Cancer. 2007 Jun;43(9):1373-84
references.pmid: 17459696
references.citation: J Clin Oncol. 2013 Dec 20;31(36):4496-503
references.pmid: 24248696
references.citation: Pediatr Blood Cancer. 2013 Oct;60(10):1714-20
references.pmid: 23681516
references.citation: N Z Med J. 2011 Jun 24;124(1337):77-89
references.pmid: 21946880
references.citation: Oncol Nurs Forum. 2008 Jan;35(1):121-30
references.pmid: 18192161
references.citation: Int J Pediatr. 2011;2011:461512
references.pmid: 22121378
references.citation: JAMA. 2013 Jun 12;309(22):2371-81
references.pmid: 23757085
references.citation: Cancer. 2005 May 15;103(10 ):2171-80
references.pmid: 15812823
references.citation: Cancer Treat Rev. 2014 Mar;40(2):327-40
references.pmid: 23871124
references.citation: Obes Facts. 2009;2(3):187-95
references.pmid: 20054224
references.citation: Pediatr Res. 2013 Oct;74(4):366-74
references.pmid: 23857296
references.citation: Cancer. 2011 May 15;117(10 Suppl):2335-41
references.pmid: 21523755
references.citation: Leuk Lymphoma. 2015 Apr;56(4):1004-11
references.pmid: 25030039
references.citation: Int J Epidemiol. 2011 Jun;40(3):685-98
references.pmid: 21245072
references.citation: J Pediatr Hematol Oncol. 2009 Apr;31(4):259-66
references.pmid: 19346877
references.citation: J Clin Oncol. 2009 May 10;27(14):2382-9
references.pmid: 19332713
references.citation: J Pediatr Oncol Nurs. 2006 May-Jun;23(3):135-42
references.pmid: 16624889
references.citation: Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008796
references.pmid: 23633361
references.citation: J Sport Exerc Psychol. 2009 Apr;31(2):267-83
references.pmid: 19454774
references.citation: Appl Physiol Nutr Metab. 2011 Jul;36 Suppl 1:S101-12
references.pmid: 21800938
references.citation: CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
references.pmid: 24488779
references.citation: J Cancer Surviv. 2013 Dec;7(4):523-34
references.pmid: 23749663
references.citation: Leuk Res Treatment. 2013;2013:592395
references.pmid: 24163773
references.citation: BMC Cancer. 2010 Nov 11;10:624
references.pmid: 21070639
references.citation: Phys Ther. 2009 Mar;89(3):286-306
references.pmid: 19147708
references.citation: J Pediatr Psychol. 2012 Mar;37(2):198-208
references.pmid: 22004885
references.citation: Arch Dis Child. 2013 Nov;98(11):902-7
references.pmid: 23986559
references.citation: J Clin Oncol. 2013 Aug 1;31(22):2799-805
references.pmid: 23796992
references.citation: Expert Rev Hematol. 2011 Apr;4(2):185-97
references.pmid: 21495928
references.citation: Cancer Nurs. 2012 Jan-Feb;35(1):48-54
references.pmid: 21558852
references.citation: Semin Oncol. 2013 Dec;40(6):784-95
references.pmid: 24331197
references.citation: J Pediatr Orthop. 1998 Sep-Oct;18(5):561-71
references.pmid: 9746401
references.citation: J Cancer Surviv. 2012 Sep;6(3):260-9
references.pmid: 22547096
references.citation: J Pediatr Oncol Nurs. 2012 Sep-Oct;29(5):246-52
references.pmid: 22907680
references.citation: J Cancer Surviv. 2010 Jun;4(2):87-100
references.pmid: 20052559
references.citation: Pediatr Blood Cancer. 2010 Apr;54(4):501-10
references.pmid: 19743298
references.citation: Cancer. 2011 May 15;117(10 Suppl):2289-94
references.pmid: 21523748
references.citation: Leukemia. 2010 Jun;24(6):1113-20
references.pmid: 20410923
references.citation: Pediatr Blood Cancer. 2013 Aug;60(8):1261-6
references.pmid: 23609993
references.citation: J Cancer Surviv. 2012 Sep;6(3):278-86
references.pmid: 22544451